To study the pathogenicity of HSPB1‐T139M mutation, we first evaluated the impact of this novel mutation on the overall biological fitness of this stable neuroblastoma cells using MTS cell viability assay (Cory, Owen, Barltrop, & Cory, 1991). This evidence concerns the gene HSPB1 and neuroblastoma.